Ibsen Awards: International Funds for Theatre Performances.
Ibsen Awards are announcing The Ibsen Scholarships 2017.
Funds amounting to NOK 2.000.000,- (approx. Euro 221.000,- /USD 235.000,-) are awarded theatre projects worldwide.
The Scholarships are applicable to individual artists, theatre companies, organizations and institutions.
- The Ibsen Scholarships award innovative theatre projects.
- The projects must act as incentives for critical discourse in regards to existential and society-related subject matters concerning Henrik Ibsen’s plays.
- Applications are submitted electronically through www.ibsenawards.com .
- Performances already staged are not eligible.
The Scholarships are awarded biennially and the applications are subject to scrutiny by an appointed jury.
The Ibsen Scholarships were initiated by the Norwegian government and will be handed out for the 9th time in 2017.
Ibsen Awards has until now handed out 29 scholarships in 22 different countries.
The application deadline for The Ibsen Scholarships is April 30th 2017.
The winners of The Ibsen Scholarships 2017 will be presented at Skien International Ibsen Conference October 18. and 19. at Teater Ibsen in Skien, Norway.
For further information, statutes and application form, kindly visit our website www.ibsenawards.com .
Like us on Facebook: https://www.facebook.com/ibsenawards/
Hilde Guri Bohlin
Phone: +47 35 90 50 50
Cell: + 47 917 67 903
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
NJ-CELGENE17.2.2018 22:02 | pressemeddelelse
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers
CELLTRION-HEALTHCARE17.2.2018 09:02 | pressemeddelelse
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study
AVANTI-COMMUNICATIONS16.2.2018 19:28 | pressemeddelelse
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana
KY-GENERAL-CABLE-CORP16.2.2018 18:07 | pressemeddelelse
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group
BOEHRINGER-INGELHEIM16.2.2018 10:05 | pressemeddelelse
Systemic Sclerosis World Congress: Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease
PHILIP-MORRIS-INTL16.2.2018 09:02 | pressemeddelelse
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum